PECAM1 and glioblastoma: We also demonstrated that FBXO22 was positively correlated with CD31 (angiogenesis marker), HIF-1α and VEGFA expression in xenograft GBM tumors, which proved that FBXO22 accelerated GBM angiogenesis and tumorigenesis.